Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial
Xiaobo Cheng, Jing Wang, Chenli Qiu, Yanling Jin, Bili Xia, Ran Qin, Huiliang Hu, Yan Jia, Xiaoyan Zhang, Jianqing Xu
Topics & Concepts
MedicineTolerabilityImmunotherapyCD8Clinical trialProgressive diseaseInternal medicineAdverse effectResponse Evaluation Criteria in Solid TumorsPhysical examinationPhases of clinical researchT cellAdenocarcinomaSurgeryOncologyGastroenterologyImmune systemImmunologyDiseaseCancerCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction